↓ Skip to main content

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Overview of attention for article published in Immunity & Ageing, November 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
66 Mendeley
Title
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
Published in
Immunity & Ageing, November 2020
DOI 10.1186/s12979-020-00207-8
Pubmed ID
Authors

Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, Carlos Hidalgo, Geydi Lorenzo, Meylan Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 14%
Researcher 8 12%
Other 6 9%
Student > Bachelor 6 9%
Student > Doctoral Student 3 5%
Other 10 15%
Unknown 24 36%
Readers by discipline Count As %
Medicine and Dentistry 13 20%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Nursing and Health Professions 4 6%
Immunology and Microbiology 4 6%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 9 14%
Unknown 27 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2023.
All research outputs
#7,048,346
of 23,539,593 outputs
Outputs from Immunity & Ageing
#147
of 387 outputs
Outputs of similar age
#148,385
of 413,646 outputs
Outputs of similar age from Immunity & Ageing
#4
of 13 outputs
Altmetric has tracked 23,539,593 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 387 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,646 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.